Prostate
ASTuTE
Shared decision making using multimodal Artificial Intelligence (MMAI) with digital histopathology for Androgen Deprivation Therapy (ADT) use in men with intermediate risk prostate cancer managed with standard of care radiotherapy.
Trial overview
Radiation Oncology
Prostate Cancer
II
Registration number: ACTRN12623000713695
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385964&isReview=true
Radiation Oncologist
Professor Jarad Martin
MBChB BSc PhD DMed, FRANZCR GAustMS

Radiation Oncologist
Dr Jeremy de Leon
BSc (Bioinformatics), M.B.B.S (Honours), FRANZCR

Chief Medical Officer, Radiation Oncologist,
Dr Marcus Dreosti
BSc, Hons LLB, MBBS (Hons) FRANZCR

Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.